Clinical trial of wellness training: Health promotion for severely mentally ill adults

Journal of Nervous and Mental Disease

Volumn 196, Issue 6, 2008, Pages 475-483

  Chafetz, Linda ^a   White, Mary ^a   Collins Bride, Gerri ^a   Cooper, Bruce A ^a   Nickens, John ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Progress Foundation   (United States)

Author keywords

Health behavior change; Health promotion; Mood disorders; Schizophrenia; Severely mentally ill

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RESIDENTIAL CARE; SELF CARE; SELF CONCEPT; SHORT FORM 36; SKILL; TRAINING; WELLBEING; ATTITUDE TO HEALTH; BIPOLAR DISORDER; COGNITIVE THERAPY; DAILY LIFE ACTIVITY; HEALTH PROMOTION; HOSPITALIZATION; MAJOR DEPRESSION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; SCHIZOPHRENIA; UNITED STATES;

ACTIVITIES OF DAILY LIVING; ADULT; ATTITUDE TO HEALTH; BIPOLAR DISORDER; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HEALTH PROMOTION; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SAN FRANCISCO; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CARE; SELF EFFICACY;

EID: 45749104770     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e31817738de     Document Type: Article

References (66)

1. Bandura A (2004) Health promotion by social cognitive means. Health Educ Behav. 1:143-164.
2. Barkham M, Connell J, Stiles WB, Miles JN, Margison F, Evans C, Mellor-Clark J (2006) Dose-effect relations and responsive regulation of treatment duration: The good enough level. J Consult Clin Psychol. 74:160-167.
3. Basu A, Meltzer HY (2006) Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era. Schizophr Res. 86:99-109.
4. BootsMiller BJ, Ribisl KM, Mowbray CT, Davidson WS, Walton MA, Herman (1998) Methods of ensuring high follow-up rates: Lessons from a longitudinal study of dual diagnosed participants. Subst Use Misuse.33:2665-2685.
5. Bradshaw T, Lovell K, Harris N (2005) Healthy living interventions and schizophrenia: A systematic review. J Adv Nurs. 49:634-654.
6. Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R (2005) Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 66:205-212.
7. Cacciola JS, Alterman AI, McLellan AT, Lin YT, Lynch KG (2007) Initial evidence for the reliability and validity of a "Lite" version of the addiction severity index. Drug Alcohol Depend. 87:297-302.
8. Chafetz L, White MC, Collins-Bride G (2004) A nursing faculty practice for the severely mentally ill: Merging practice with research. Nurs Outlook. 52:209-214.
9. Chafetz L, White MC, Collins-Bride G, Nickens J, Cooper BA (2006) Predictors of physical functioning among adults with severe mental illness. Psychiatr Serv. 57:225-231.
10. Curkendal SM, Mo J, Glasser DB, Rose Stang M, Jones JK (2003) Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiaty. 65:715-720.
11. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ (2005) Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA293:43-53.
12. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV (2006) Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry. 67:215-221.
13. Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H (2002) Medical morbidity, mental illness and substance use disorders. Psychiatr Serv. 53:861-867.
14. Enger C, Weatherby L, Reynolds RF, Glasser DB, Walker AM (2004) Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis. 192:19-27.
15. Essock SM, Dowden S, Constantine NT, Katz L, Swartz MS, Meador KG, Osher FC, Rosenberg SD; Five-Site Health and Risk Study Research Committee (2003) Risk factors for HIV, hepatitis B and hepatitis C among persons with severe mental illness. Psychiatr Serv. 54:836-841.
16. Evans S, Newton R, Higgins S (2005) Nutritional intervention to prevent weight gain in patients commenced on olanzapine: A randomized controlled trial. Aust N Z J Psychiatry. 39:479-486.
17. Faulkner G, Soundy A, Lloyd K (2003) Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatrica Scandinavica 108(5): 324-332.
18. Faulkner G, Cohn T, Remington G (2007) Interventions to reduce weight gain in schizophrenia. Cochrane Database of Systematic Reviews, 24: CD005148.
19. Faulkner G, Cohn T, Remington G (2007) Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev. 1:CD005148.
20. Fields S, Weisman GK (1995) Crisis residential treatment: An alternative to hospitalization. New Dir Ment Health Serv. 67:23-31.
21. Filik R, Sipos A, Kehoe PG, Burns T, Cooper SJ, Stevens H, Laugharne R, Young G, Perrington S, McKendrick J, Stephenson D, Harrison G (2006) The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand. 113:298-305.
22. Goldfinger SM, Schutt RK, Seidman LJ, Turner WM, Penk WE, Tolomiczenko GS (1996) Self-report and observer measures of substance abuse among homeless mentally ill persons in the cross-section and over time. J Nerv Ment Dis. 184:667-672.
23. Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 150:1115-1121.
24. Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L (2004) Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry. 161:2317-2319.
25. Hoffmann VP, Ahl J, Meyers A, Schuh L, Shults KS, Collins DM, Jensen L (2005) Wellness intervention for patients with serious and persistent mental illness. J Clin Psychiatry 56:1576-9.
26. Hox J (2002) Multilevel Analysis: Techniques and Applications. Mahwah (NJ): Lawrence Erlbaum Associates.
27. Hoyer EH, Mortensen PB, Olesen AV (2000) Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br J Psychiatry. 176:76-82.
28. Johnson-Masotti AP, Weinhardt LS, Pinkerton SD, Otto-Salaj LL (2003) Efficacy and cost-effectiveness of the first generation of HIV prevention interventions for people with severe and persistent mental illness. J Ment Health Policy Econ. 6:23-35.
29. Jones DR, Macias C, Barreira PJ, Fisher W, Hargreaves W, Garding CM (2004) Prevalence, severity and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv. 55:1250-1257.
30. Jones SH, Thornicroft G, Coffey M, Dunn G (1995) A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 166:654-659.
31. Kopelowicz A, Liberman RP, Zarate R (2006) Recent advances in social skills training for schizophrenia. Schizophr Bull. 32:S12-S23.
32. Kreft IG, de Leeuw J, Aiken L (1995) The effect of different forms of centering in hierarchical linear models. Multivariate Behav Res. 30:1-21.
33. Lamberti JS, Olson D, Crilly JF, Olivares T, Tu X, Tang W, Wiener K, Dvorin S, Dietz MB (2006) Prevalence of the metabolic syndrome among patients receiving clozapine. Am J Psychiatr. 163:1273-1276.
34. Lehman AF (1988) A quality of life interview for the chronically mentally ill. Eval Program Plann. 11:51-62.
35. Lesaffre E, Spiessens B (2001) On the effect of the number of quadrature points in a logistic random-effects model: An example. Appl Stat. 50:325-335.
36. Loh C, Meyer JM, Leckband SG (2006) A comprehensive review of behavioral interventions for weight management in schizophrenia. Ann Clin Psychiatry. 18:23-31.
37. Macdonald EM, Pica S, McDonald S, Hayes R, Baglioni AJ (1988) Stress in early psychosis. Role of symptoms, self-efficacy and social support in coping with stress. Br J Psychiatry. 173:S122-S129.
38. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S (2004) Physical health monitoring of patients with schizophrenia. Am J Psychiatry, 161: 1334-49.
39. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Scott Stroup T, Lieberman JA (2005) Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 80:19-32.
40. McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, Mudaliar S, Barrio C, O'Hanlon K, Griver K, Sirkin A, Jeste DV (2006) A lifestyle intervention for older schizophrenia patients with diabetes mellitus: A randomized controlled trial. Schizophr Res. 8:36-44.
41. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992) The fifth edition of the addiction severity index. J Subst Abuse Treat. 9:199-213.
42. Moller MD, Murphy MF (1997) The three r's rehabilitation program: A prevention approach for the management of relapse symptoms associated with psychiatric diagnoses. J Psychiatr Rehab. 20:42-48.
43. Mueser KT, Corrigan PW, Hilton DW, Tanzman B, Schaub A, Gingerich S, Essock SM, Tarrier N, Morey B, Vogel-Scibilia S, Herz MI (2002) Illness management and recovery: A review of the research. Psychiatr Serv. 53:1272-1212.
44. Mueser KT, Meyer PS, Penn DL, Clancy R, Clancy DM, Salyers MP (2006) The illness management and recovery program: Rationale, development and preliminary findings. Schizophr Bull. 32:S32-S43.
45. Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, Lieberman JA (2006) Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 86:15-22.
46. Osby U, Correia N, Brandt L, Ekbom A, Sparen P (2000) Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 45:21-28.
47. Parkerson GRJr, Broadhead WE, Tse CK (1993) The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity. J Clin Epidemiol. 46:379-393.
48. Parkerson GR (2002) User's Guide for Duke Health Measures. Durham (NC): Department of Community and Family Medicine, Duke University Medical Center.
49. Pratt SI, Mueser KT, Smith TE, Lu W (2005) Self-efficacy and psychosocial functioning in schizophrenia: A mediational analysis. Schizophr Res. 78:187-197.
50. Rabe-Hesketh S, Skrondal A, Pickles A (2002) Reliable estimation of generalised linear models using adaptive quadrature. Stata J. 2:1-21.
51. Rabe-Hesketh S, Skrondal A, Pickles A (2005) Maximum likelihood estimation of limited and discrete dependent variable models with nested random effects. J Econometrics. 128:301-323.
52. Rabe-Hesketh S, Toulopoulou T, Murray RM (2001) Multilevel modeling of cognitive function in schizophrenic patients and their first degree relatives. Multivariate Behav Res Special Issue Multilevel Mod. 36: 279-298.
53. Raudenbush SW, Bryk AS (2002) Hierarchical Linear Models: Applications and Data Analysis Methods (2nd ed). Thousand Oaks: Sage. Richardson CR, Faulkner G, McDevitt J, Skrinar GS, Hutchinson S, Piette JD (2005) Integrating physical activity into mental health services for persons with serious mental illness. Psychiatr Serv. 56:324-331.
54. Rodriguez G, Goldman N (2001) Improved estimation procedures for multilevel models with binary response: A case-study. Appl Stat. 164:339-355.
55. Russo J, Trujillo CA, Wingerson D, Decker K, Ries R, Wetzler H, Roy IP (1998) The MOS 36-item short form health survey: Reliability, validity and preliminary findings in schizophrenic outpatients. Med Care. 36:752-756.
56. Sciolla A, Patterson TL, Wetherell JL, McAdams LA, Jeste DV (2003) Functioning and well-being of middle-aged and older patients with schizophrenia: Measurement with the 36-item Short-Form (SF-36) health survey. Am J Geriatr Psychiatry. 11:629-637.
57. Sernyak MJ, Gulanski B, Rosenheck R (2005) Undiagnosed hyperglycemia in patients treated with atypical antipsychotics. J Clin Psychiatry. 66: 1463-1467.
58. Singer JD, Willett JB (2003) Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press.
59. SPSS (2004) SPSS for Windows, Release 13. Chicago: SPSS Inc.
60. StataCorp (2005) Stata Statistical Software: Release 9.1. College Station (TX): Stata Corporation.
61. Taylor V, MacQueen G (2006) Associations between bipolar disorder and metabolic syndrome: A review. J Clin Psychiatry. 67:1034-1041.
62. Ware JE (2000) SF-36 health survey update. Spine. 25:3130-3139.
63. White MC, Chafetz L, Collins-Bride G, Nickens J (2006) History of Arrest, Incarceration, and Victimization in Community Based Severely Mentally III. Journal of Community Health 319:123-135.
64. Wilhelm K, Arnold K, Niven H, Richmond R (2004) Grey lungs and blue moods: Smoking cessation in the context of lifetime depression history. Aust N Z J Psychiatry. 38:896-905.
65. Williams JM, Ziedonis D (2004) Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 29:1067-1083.
66. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD (2005) Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations. J Psychiatr Pract. 11:315-339.